• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶瘤性新城疫病毒在癌症治疗中的应用:旧挑战与新方向。

Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

机构信息

Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029, USA.

出版信息

Future Microbiol. 2012 Mar;7(3):347-67. doi: 10.2217/fmb.12.4.

DOI:10.2217/fmb.12.4
PMID:22393889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4241685/
Abstract

Newcastle disease virus (NDV) is an avian paramyxovirus, which has been demonstrated to possess significant oncolytic activity against mammalian cancers. This review summarizes the research leading to the elucidation of the mechanisms of NDV-mediated oncolysis, as well as the development of novel oncolytic agents through the use of genetic engineering. Clinical trials utilizing NDV strains and NDV-based autologous tumor cell vaccines will expand our knowledge of these novel anticancer strategies and will ultimately result in the successful use of the virus in the clinical setting.

摘要

新城疫病毒(NDV)是一种禽副黏病毒,已被证明对哺乳动物癌症具有显著的溶瘤活性。本综述总结了阐明 NDV 介导的溶瘤机制的研究,以及通过基因工程开发新型溶瘤剂的研究。利用 NDV 株和基于 NDV 的自体肿瘤细胞疫苗进行的临床试验将扩大我们对这些新型抗癌策略的认识,并最终导致该病毒在临床环境中的成功应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7662/4241685/ab213193841f/nihms642760f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7662/4241685/497d00d2a5a2/nihms642760f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7662/4241685/ab213193841f/nihms642760f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7662/4241685/497d00d2a5a2/nihms642760f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7662/4241685/ab213193841f/nihms642760f2.jpg

相似文献

1
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.溶瘤性新城疫病毒在癌症治疗中的应用:旧挑战与新方向。
Future Microbiol. 2012 Mar;7(3):347-67. doi: 10.2217/fmb.12.4.
2
Newcastle disease virus as an oncolytic agent.新城疫病毒作为一种溶瘤剂。
Indian J Med Res. 2009 Nov;130(5):507-13.
3
[Progress in using Newcastle disease virus for tumor therapy: a review].[新城疫病毒用于肿瘤治疗的研究进展:综述]
Sheng Wu Gong Cheng Xue Bao. 2010 Aug;26(8):1031-6.
4
Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.用于癌症治疗的溶瘤新城疫病毒的基因改造
J Virol. 2016 May 12;90(11):5343-5352. doi: 10.1128/JVI.00136-16. Print 2016 Jun 1.
5
Newcastle disease virus: a promising agent for tumour immunotherapy.新城疫病毒:肿瘤免疫治疗的有前途的制剂。
Clin Exp Pharmacol Physiol. 2012 Aug;39(8):725-30. doi: 10.1111/j.1440-1681.2011.05662.x.
6
Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.构建重组新城疫病毒意大利株用于肿瘤溶瘤病毒治疗。
Hum Gene Ther. 2012 Jul;23(7):700-10. doi: 10.1089/hum.2011.207. Epub 2012 Apr 18.
7
Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting.携带 IL24 基因的溶瘤新城疫病毒通过抑制肿瘤生长和血管生成发挥抗肿瘤作用。
Int Immunopharmacol. 2024 Jul 30;136:112305. doi: 10.1016/j.intimp.2024.112305. Epub 2024 May 31.
8
Safety and clinical usage of newcastle disease virus in cancer therapy.新城疫病毒在癌症治疗中的安全性及临床应用
J Biomed Biotechnol. 2011;2011:718710. doi: 10.1155/2011/718710. Epub 2011 Oct 26.
9
Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.溶瘤新城疫病毒作为一种有前景的抗癌疗法。一种具有打破治疗抗性潜力的生物制剂。
Expert Opin Biol Ther. 2015;15(12):1757-71. doi: 10.1517/14712598.2015.1088000. Epub 2015 Oct 5.
10
Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.新城疫病毒抗癌的三种特性分析:肿瘤选择性复制、抗肿瘤细胞毒性和免疫刺激。
Methods Mol Biol. 2012;797:177-204. doi: 10.1007/978-1-61779-340-0_13.

引用本文的文献

1
Polio virotherapy provokes MDA5 signaling and CD4 T cell help to mediate cancer vaccination.脊髓灰质炎病毒疗法激发黑色素瘤分化相关基因5信号传导和CD4 T细胞辅助作用以介导癌症疫苗接种。
Microbiol Mol Biol Rev. 2025 Jul 8:e0004024. doi: 10.1128/mmbr.00040-24.
2
Recombinant oncolytic virus NDV-anti-VEGFR2 enhances radiotherapy sensitivity in NSCLC by targeting VEGF signaling and impairing DNA repair.重组溶瘤病毒NDV-抗VEGFR2通过靶向VEGF信号通路和损害DNA修复来增强非小细胞肺癌的放射敏感性。
Gene Ther. 2025 May 17. doi: 10.1038/s41434-025-00540-x.
3
Killing cancer quickly: inducing hyper-acute rejection of patient tumors.

本文引用的文献

1
Virulence of Newcastle disease virus: what is known so far?新城疫病毒的毒力:目前已知的情况?
Vet Res. 2011 Dec 23;42(1):122. doi: 10.1186/1297-9716-42-122.
2
Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus.维甲酸诱导基因 I 和 I 型干扰素受体对细胞抵抗新城疫病毒感染的重要性。
Int J Oncol. 2012 Jan;40(1):287-98. doi: 10.3892/ijo.2011.1222. Epub 2011 Oct 4.
3
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer.
快速杀死癌症:诱导对患者肿瘤的超急性排斥反应。
Cell Res. 2025 Mar 13. doi: 10.1038/s41422-025-01099-3.
4
IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer.编码IL-12的新城疫病毒在非小细胞肺癌原位模型中与嵌合抗原受体T细胞协同作用。
Mol Ther Oncol. 2024 Oct 28;32(4):200899. doi: 10.1016/j.omton.2024.200899. eCollection 2024 Dec 19.
5
Newcastle disease virus infection induces parthanatos in tumor cells via calcium waves.新城疫病毒感染通过钙波诱导肿瘤细胞发生副凋亡。
PLoS Pathog. 2024 Dec 2;20(12):e1012737. doi: 10.1371/journal.ppat.1012737. eCollection 2024 Dec.
6
Clinical and Translational Landscape of Viral Gene Therapies.病毒基因治疗的临床和转化前景。
Cells. 2024 Nov 19;13(22):1916. doi: 10.3390/cells13221916.
7
Newcastle disease virus promotes pyroptosis in medulloblastoma cells by regulating interferon-gamma-mediated guanylate-binding protein 1 expression and activating caspase-4.新城疫病毒通过调节干扰素-γ介导的鸟苷酸结合蛋白1表达并激活半胱天冬酶-4来促进髓母细胞瘤细胞焦亡。
Cytojournal. 2024 Oct 30;21:39. doi: 10.25259/Cytojournal_39_2024. eCollection 2024.
8
Mitochondrial Dysfunction and Metabolic Disturbances Induced by Viral Infections.病毒感染诱导的线粒体功能障碍和代谢紊乱。
Cells. 2024 Oct 29;13(21):1789. doi: 10.3390/cells13211789.
9
Anticancer effect of the oncolytic Newcastle disease virus harboring the PTEN gene on glioblastoma.携带PTEN基因的溶瘤新城疫病毒对胶质母细胞瘤的抗癌作用
Oncol Lett. 2024 Oct 16;29(1):6. doi: 10.3892/ol.2024.14752. eCollection 2025 Jan.
10
Nanoengineering-armed oncolytic viruses drive antitumor response: progress and challenges.纳米工程武装的溶瘤病毒驱动抗肿瘤反应:进展与挑战
MedComm (2020). 2024 Oct 10;5(10):e755. doi: 10.1002/mco2.755. eCollection 2024 Oct.
融合性新城疫病毒治疗头颈部癌症的疗效。
Head Neck. 2011 Oct;33(10):1394-9. doi: 10.1002/hed.21609. Epub 2010 Nov 4.
4
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.静脉注射多机制癌症靶向溶瘤痘病毒在人体中的应用。
Nature. 2011 Aug 31;477(7362):99-102. doi: 10.1038/nature10358.
5
Cytoplasmic DNA innate immune pathways.细胞质 DNA 先天免疫途径。
Immunol Rev. 2011 Sep;243(1):99-108. doi: 10.1111/j.1600-065X.2011.01051.x.
6
Apoptin enhances the oncolytic properties of Newcastle disease virus.凋亡素增强了新城疫病毒的溶瘤特性。
Intervirology. 2012;55(4):276-86. doi: 10.1159/000328325. Epub 2011 Aug 24.
7
Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs.表达人类免疫缺陷病毒 1 型包膜糖蛋白的新城疫病毒在豚鼠中诱导强烈的黏膜和血清抗体应答。
J Virol. 2011 Oct;85(20):10529-41. doi: 10.1128/JVI.05050-11. Epub 2011 Aug 17.
8
The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain.新城疫病毒的基质(M)蛋白通过其 BH3 结构域与人 bax 结合。
Virol J. 2011 Aug 3;8:385. doi: 10.1186/1743-422X-8-385.
9
Efficacy of Newcastle disease virus recombinant expressing avian influenza virus H6 hemagglutinin against Newcastle disease and low pathogenic avian influenza in chickens and turkeys.表达禽流感病毒H6血凝素的新城疫病毒重组体对鸡和火鸡新城疫及低致病性禽流感的疗效。
Avian Dis. 2011 Jun;55(2):201-11. doi: 10.1637/9539-092710-Reg.1.
10
Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.禽类副黏病毒融合和血凝素-神经氨酸酶蛋白在复制、嗜性和致病性中的作用。
J Virol. 2011 Sep;85(17):8582-96. doi: 10.1128/JVI.00652-11. Epub 2011 Jun 15.